The Food and Drug Administration approved the drug for adult patients with bullous pemphigoid, which mainly affects the ...

Approval based on pivotal results showing improvements in sustained disease remission and reductions in itch and oral corticosteroid use compared to placebo in adults with BP BP is a chronic, ...

Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid  Approval based on pivotal results showing improvements in sustained disease remission and ...

Paris: Sanofi has received approval from the US Food and Drug Administration (FDA) for Dupixent (dupilumab) for the treatment ...

Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid Approval based on pivotal results showing improvements in sustained disease remission and reductions ...

Discover life-changing eczema treatments and remedies that provide real relief. From prescription breakthroughs to natural ...

LONDON, 20 Jun. 2025 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information ...

Medically reviewed by William Truswell, MD Eczema is a long-term condition where an overactive immune response causes skin inflammation (swelling) and irritation. Eczema leads to dry, itchy patches of ...